Sphingosine 1-phosphate (S1P)/S1P receptor 1 signaling regulates receptor activator of NF-κB ligand (RANKL) expression in rheumatoid arthritis

Biochemical and Biophysical Research Communications

Volumn 419, Issue 2, 2012, Pages 154-159

  Takeshita, Harunori ^a   Kitano, Masayasu ^a   Iwasaki, Tsuyoshi ^a   Kitano, Sachie ^a   Tsunemi, Sachi ^a   Sato, Chieri ^a   Sekiguchi, Masahiro ^a   Azuma, Naoto ^a   Miyazawa, Keiji ^b   Hla, Timothy ^c   Sano, Hajime ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b KISSEI PHARMACEUTICAL CO LTD   (Japan)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

RANKL; Rheumatoid arthritis; Sphingosine 1 phosphate

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; PERTUSSIS TOXIN; SPHINGOSINE 1 PHOSPHATE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CD4+ T LYMPHOCYTE; CELL HYPERPLASIA; CELL ISOLATION; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE; SYNOVIUM;

ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; LYSOPHOSPHOLIPIDS; RANK LIGAND; RECEPTORS, LYSOSPHINGOLIPID; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPHINGOSINE; SYNOVIAL FLUID;

EID: 84857999059     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.103     Document Type: Article

References (30)

1. Sanchez T., Hla T. Structural and functional characteristics of S1P receptors. J. Cell Biochem. 2004, 92:913-922.
2. Hla T. Signaling and biological actions of sphingosine 1-phosphate. Pharmacol. Res. 2003, 47:401-407.
3. Spiegel S., Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 2003, 4:397-407.
4. Hla T. Physiological and pathological actions of sphingosine 1-phosphate. Semin. Cell Dev. Biol. 2004, 15:513-520.
5. Kitano M., Hla T., Sekiguchi M., Kawahito Y., Yoshimura R., Miyazawa K., Iwasaki T., Sano H., Saba J.D., Tam Y.Y. Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. Arthritis Rheum. 2006, 54:742-753.
6. Sano H., Hla T., Maier J.A., Crofford L.J., Case J.P., Maciag T., Wilder R.L. In vitro cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J. Clin. Invest. 1992, 89:97-108.
7. Ben-Av P., Crofford L.J., Wilder R.L., Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 1995, 372:83-87.
8. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S., Saito S., Inoue K., Kamatani N., Gillespie M.T., Martin T.J., Suda T. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 1999, 103:1345-1352.
9. Takahashi N., Udagawa N., Suda T. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem. Biophys. Res. Commun. 1999, 256:449-455.
10. Udagawa N., Kotake S., Kamatani N., Takahashi N., Suda T. The molecular mechanism of osteoclastogenesis in rheumatoid arthritis. Arthritis Res. 2002, 4:281-289.
11. Ryu J., Kim H.J., Chang E.J., Huang H., Banno Y., Kim H.H. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J. 2006, 25:5840-5851.
12. Ishii M., Egen J.G., Klauschen F., Meier-Schellersheim M., Saeki Y., Vacher J., Proia R.L., Germain R.N. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature. 2009, 26:524-528.
13. Miyazawa K., Mori A., Okudaira H. Establishment and characterization of a novel human rheumatoid fibroblast-like synoviocyte line, MH7A, immortalized with SV40 T antigen. J. Biochem. 1998, 124:1153-1162.
14. Sekiguchi M., Iwasaki T., Kitano M., Kuno H., Hashimoto N., Kawahito Y., Azuma M., Hla T., Sano H. Role of sphingosine 1-phosphate in the pathogenesis of Sjogren's syndrome. J Immunol. 2008, 180:1921-1928.
15. Andre-Garnier E., Robillard N., Costa-Mattioli M., Besse B., Billaudel S., Imbert-Marcille B.M. A one-step RT-PCR and a flow cytometry method as two specific tools for direct evaluation of human herpesvirus-6 replication. J. Virol. Methods. 2003, 108:213-222.
16. Kim J.I., Jo E.J., Lee H.Y., Cha M.S., Min J.K., Choi C.H., Lee Y.M., Choi Y.A., Baek S.H., Ryu S.H., Lee K.S., Kwak J.Y., Bae Y.S. Sphingosine 1-phosphate in amniotic fluid modulates cyclooxygenase-2 expression in human amnion-derived WISH cells. J. Biol. Chem. 2003, 278:31731-31736.
17. Lee C.K., Lee E.Y., Chung S.M., Mun S.H., Yoo B., Moon H.B. Effects of disease-modifying anti-rheumatic drugs and anti-inflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand. Arthritis Rheum. 2004, 50:3831-3843.
18. Catrina A.I., af Klint E., Ernestam S., Catrina S.B., Makrygiannakis D., Botusan I.R., Klareskog L., Ulfgren A.K. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis. Arthritis Rheum. 2006, 54:76-81.
19. Wei X., Zhang X., Zuscik M.J., Drissi M.H., Schwarz E.M., O'Keefe R.J. Fibroblasts express RANKL and support osteoclastogenesis in a COX-2-dependent manner after stimulation with titanium particles. J. Bone Miner. Res. 2005, 20:1136-1148.
20. Lee M.J., Evans M., Hla T. The inducible G protein-coupled receptor edg-1 signals via the G(i)/mitogen-activated protein kinase pathway. J. Biol. Chem. 1996, 271:11272-11279.
21. Pederson L., Ruan M., Westendorf J.J., Khosla S., Oursler M.J. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc. Natl. Acad. Sci. USA 2008, 105:20764-20769.
22. Brinkmann V., Davis M.D., Heise C.E., Albert R., Cottens S., Hof R., Bruns C., Prieschi E., Baumruker T., Hiestand P., Foster C.A., Zollinger M., Lynch K.R. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 2002, 277:21453-21457.
23. Graler M.H., Goetzl E.J. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J. 2004, 18:551-553.
24. Pham T.H., Okada T., Matloubian M., Lo C.G., Cyster J.G. S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress. Immunity. 2007, 28:122-133.
25. Tsunemi S., Iwasaki T., Kitano S., Imado T., Miyazawa K., Sano H. Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model. Clin. Immunol. 2010, 136:197-204.
26. Matsuura M., Imayoshi T., Okumoto T. Effect of FTY720, a novel immunosuppressant, on adjuvant- and collagen-induced arthritis in rats. Int. J. immunopharmacol. 2000, 22:323-331.
27. Mclnnes I.B., Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 2007, 7:429-442.
28. Xia P., Gamble J.R., Rye K.A., Wang L., Hii C.S., Cockerill P., Khew-Goodall Y., Bert A.G., Barter P.J., Vadas M.A. Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. Proc. Natl. Acad. Sci. USA 1998, 95:14196-14201.
29. Billich A., Bornancin F., Mechtcheriakova D., Natt F., Huesken D., Baumruker T. Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1 beta and TNF-alpha induced production of inflammatory mediators. Cell signal. 2005, 17:1203-1217.
30. Lai W.Q., Irwan A.W., Goh H.H., Howe H.S., Yu D.T., Valle-Onate R., Mclnnes I.B., Melendez A.J., Leung B.P. Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis. J. Immunol. 2008, 181:8010-8017.